First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

While the drug may not be strong enough to treat colon cancer on its own, researchers believe it could enhance more ...

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role ...

New research suggests that weight loss injections, also known as GLP-1 receptor agonists, may have a significant anti-cancer ...

Scientists have discovered that a promising new anticancer medicine currently in development could be made from unknown ...

Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Indigenous Nigerian food plants show promise in fighting cancer by targeting cell death and inflammation, offering support ...